COVID-19 Vaccine Safety: From Bench to Bedside 21 May 2021 Within a year of the pandemic being announced, several COVID-19 vaccines were approved and administered to populations around the world. There have been various successes and challenges related to the development and deployment of COVID-19 vaccines and there is significant global interest in ensuring they are safe and effective. Healthcare professionals need credible information to build trust with their patients and answer their questions. Asian Development Bank and BMJ experts discussed COVID-19 vaccine safety in clinical trials, post-authorization safety methods, and risk communication. This free webinar was part of the BMJ/ADB COVID-19 Information Centre, providing updated clinical decision support from BMJ Best Practice and e-learning resources from BMJ Learning to frontline healthcare professionals. Speakers Dr. Patrick L. Osewe, Chief of Health Sector Group, Asian Development Bank Dr. Stephen Prior, Microbiologist, and President of Therax, Inc., USA Dr. Daniel Salmon, Director of the Institute for Vaccine Safety, John Hopkins Bloomberg School of Public Health, USA Dr. Priscilla Rupali, Infectious diseases physician and Professor, Department of Infectious Diseases, Christian Medical College, Vellore, India Moderator Dr. Kieran Walsh, Clinical Director, BMJ Program and Learning Materials 21 May 2021 Session / Activity Title Speaker(s) Presentation 1 SARS-CoV-2 and COVID-19 Clinical Trials and Vaccine Safety Dr. Stephen Prior shared his insight on vaccination, vaccine safety, and efficacy. He also discussed the comparison of vaccine development processes… Stephen Prior Presentation 2 Post-Authorization Safety Monitoring This presentation gives an overview of Dr. Salmon's presentation on why safety monitoring is important after vaccination. Dr. Salmon also shared… Daniel Salmon Presentation 3 Risk Communication: COVID-19 Vaccine Dr. Priscilla Rupali, in this presentation, shared insights on risk communications that emerged from the COVID-19 pandemic and how it has impacted… Priscilla Rupali Disclaimer The views expressed on this website are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent. ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. By making any designation of or reference to a particular territory or geographic area, or by using the term “country” in this document, ADB does not intend to make any judgments as to the legal or other status of any territory or area. Event Coordinator/s Michelle Apostol Lalitha Bhagavatheeswaran ADB Organizer/s Human and Social Development Sector Office Read Also ADB COVID-19 Response Partner Organization/s BMJ Topics Health